News from Siemens Healthineers
COVID-19 Antigen Test achieved CE Mark for easier specimen collection from the frontal part of the nose
Siemens Healthineers announced today CE mark has been achieved to use anterior nose swab sampling for the CLINITEST Rapid COVID-19 Antigen test. This sampling method can be less cumbersome and time consuming for both the provider and the patient.
CEO Bernd Montag reflects on a year of shadow and light
Gratitude for the rays of hope given the darkness of the pandemic and all its effects – this is important to Bernd Montag, CEO of Siemens Healthineers. After all, it goes hand in hand with an awareness of the immense efforts made collectively to meet this challenge. Read the full LinkedIn article.
Siemens Healthineers proposes Peer Schatz to Annual Shareholders' Meeting as new Supervisory Board member
The Supervisory Board of Siemens Healthineers AG is proposing a new Supervisory Board member to the shareholders for election at the Annual Shareholders' Meeting on February 12, 2021: Peer Schatz (55), long-serving CEO of QIAGEN N.V., a leading global provider of complete solutions for gaining molecular insights from biological samples.
Virtual AACC: Highlights from laboratory diagnostics that have a strong impact on the industry
This year's AACC Annual Scientific Meeting & Clinical Lab Expo from December 13 to 17, which took place virtually for the first time in its history, presented highly automated solutions that minimize contact and increase laboratory efficiency and safety. The congress was closely accompanied by the Siemens Healthineers Shape 21 Forum.
Liver fibrosis: Patients can be at risk of death even without exhibiting symptoms
A well-functioning liver is of vital importance. Yet diseases of the liver are among the top five causes of death among the middle-aged in many industrialized countries today. Learn more about the development of liver fibrosis, diagnostic procedures, and how not to get it.